These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

266 related items for PubMed ID: 8420201

  • 1. Dopa-unresponsive pure akinesia or freezing. A condition within a wide spectrum of PSP?
    Imai H, Nakamura T, Kondo T, Narabayashi H.
    Adv Neurol; 1993; 60():622-5. PubMed ID: 8420201
    [No Abstract] [Full Text] [Related]

  • 2. Nosological concept of juvenile parkinsonism with reference to the dopa-responsive syndrome.
    Yokochi M.
    Adv Neurol; 1993; 60():548-52. PubMed ID: 8420189
    [No Abstract] [Full Text] [Related]

  • 3. Compassionate trial of levodopa carbidopa intestinal gel infusion in two patients with progressive supranuclear palsy.
    Bhidayasiri R, Jitkritsadakul O, Boonrod N, Rerknimitr R.
    Clin Neurol Neurosurg; 2014 Jan; 116():1-3. PubMed ID: 24388506
    [No Abstract] [Full Text] [Related]

  • 4. Pure akinesia: an atypical manifestation of progressive supranuclear palsy.
    Matsuo H, Takashima H, Kishikawa M, Kinoshita I, Mori M, Tsujihata M, Nagataki S.
    J Neurol Neurosurg Psychiatry; 1991 May; 54(5):397-400. PubMed ID: 1865200
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. "Applause sign" helps to discriminate PSP from FTD and PD.
    Dubois B, Slachevsky A, Pillon B, Beato R, Villalponda JM, Litvan I.
    Neurology; 2005 Jun 28; 64(12):2132-3. PubMed ID: 15985587
    [Abstract] [Full Text] [Related]

  • 7. [Decarboxylase inhibitors combined with L-dopa in the treatment of Parkinson's disease].
    Rondot P.
    Rev Prat; 1974 Mar 11; 24(15):1211-2, 1215-6, 1219. PubMed ID: 4416964
    [No Abstract] [Full Text] [Related]

  • 8. Binswanger's disease presenting as levodopa-responsive parkinsonism: clinicopathologic study of three cases.
    Mark MH, Sage JI, Walters AS, Duvoisin RC, Miller DC.
    Mov Disord; 1995 Jul 11; 10(4):450-4. PubMed ID: 7565825
    [Abstract] [Full Text] [Related]

  • 9. Parkinson's disease.
    Lieberman AN.
    Compr Ther; 1986 Mar 11; 12(3):25-9. PubMed ID: 3486090
    [No Abstract] [Full Text] [Related]

  • 10. [An autopsy case of progressive supranuclear palsy showing "pure akinesia without rigidity and tremor and with no effect by L-dopa therapy (Imai)"].
    Homma Y, Takahashi H, Takeda S, Ikuta F.
    No To Shinkei; 1987 Feb 11; 39(2):183-7. PubMed ID: 3828155
    [Abstract] [Full Text] [Related]

  • 11. Apomorphine test in de novo Parkinson's disease.
    Bonuccelli U, Piccini P, Del Dotto P, Pavese N, D'Antonio P, Muratorio A.
    Funct Neurol; 1992 Feb 11; 7(4):295-8. PubMed ID: 1427361
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Early detection of L-dopa response in parkinsonian patients with a standardized tracking test.
    Albani C, Buck A.
    Adv Neurol; 1993 Feb 11; 60():386-9. PubMed ID: 8420158
    [No Abstract] [Full Text] [Related]

  • 14. The ratio of square wave jerk rates to blink rates distinguishes progressive supranuclear palsy from Parkinson disease.
    Altiparmak UE, Eggenberger E, Coleman A, Condon K.
    J Neuroophthalmol; 2006 Dec 11; 26(4):257-9. PubMed ID: 17204917
    [Abstract] [Full Text] [Related]

  • 15. The apomorphine test in parkinsonian syndromes.
    D'Costa DF, Abbott RJ, Pye IF, Millac PA.
    J Neurol Neurosurg Psychiatry; 1991 Oct 11; 54(10):870-2. PubMed ID: 1744640
    [Abstract] [Full Text] [Related]

  • 16. [L-dopa therapy of parkinson syndrome].
    Kapfhammer HP, Kuss HJ, Rüther E.
    Nervenarzt; 1985 Feb 11; 56(2):57-68. PubMed ID: 3920542
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Grandma's eyes.
    Syed H, Harris S, Dubrey S.
    Lancet; 2003 Mar 29; 361(9363):1083. PubMed ID: 12672311
    [No Abstract] [Full Text] [Related]

  • 19. Is the decreasing responsiveness of axial motor symptoms to L-dopa in elderly parkinsonian patients related to age-associated nonparkinsonian pathologies?
    Ransmayr G, Künig G, Neubauer M, Wagner M, Bösch S, Kreczy-Kleedorfer B.
    Adv Neurol; 1993 Mar 29; 60():685-9. PubMed ID: 8420211
    [No Abstract] [Full Text] [Related]

  • 20. Levodopa treatment of Parkinson's syndrome: past and future.
    Pletscher A.
    Adv Neurol; 1990 Mar 29; 53():469-73. PubMed ID: 2239486
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 14.